title: [Atypical malignant hyperthermia. A higher incidence than expected].
authors.forename: E
authors.initials: E
authors.lastname: Herrero
authors.forename: F
authors.initials: F
authors.lastname: Casinello
authors.forename: J
authors.initials: J
authors.lastname: de Stefano
authors.forename: J
authors.initials: J
authors.lastname: Fernández-Guisasola
authors.forename: A
authors.initials: A
authors.lastname: Pérez-Gallardo
mesh_terms: D018685:Anesthetics, Inhalation / Q000009:adverse effects*; D002675:Child, Preschool; D005260:Female; D005483:Flushing / Q000139:chemically induced; D006221:Halothane / Q000009:adverse effects*; D006801:Humans; D015994:Incidence; D008305:Malignant Hyperthermia / Q000097:blood / Q000175:diagnosis / Q000453:epidemiology* / Q000209:etiology; D009467:Neuromuscular Depolarizing Agents / Q000009:adverse effects*; D013030:Spain / Q000453:epidemiology; D013285:Strabismus / Q000601:surgery; D013390:Succinylcholine / Q000009:adverse effects*; D013610:Tachycardia / Q000139:chemically induced*
chemical_list: D018685:Anesthetics, Inhalation; D009467:Neuromuscular Depolarizing Agents; D013390:Succinylcholine; D006221:Halothane